KEYS vs RNXT · P/E 57, rev $4.98B vs rev $266.0K
Keysight Technologies Inc (KEYS) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the KEYS and RNXT stock pages for the full models.
Not investment advice.